Investing Profile

Mike Dybbs

InvestorVC
Partner at Samsara BioCapital
samsaracap.com/mike-dybbs/Burlingame, California
Photo of Mike Dybbs, Partner at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Harvard University Network
598 CONNECTIONS
University of California, Berkeley Network
501 CONNECTIONS
Boston Consulting Group (BCG) Network
288 CONNECTIONS
cb
$10.0M - $100.0M
$25.0M
15
$310.1M
CompanyStageDateRound SizeTotal Raised
Arcellx
Series CApr 2021$120M
$120M
Ionpath
Series BSep 2020$18M
$18M
Co-investors: Jenny Rooke (Genoa Ventures)
Nkarta Therapeutics
Series BSep 2019$110M
$110M
Co-investors: Fouad Azzam (EQT Life Sciences)
Sutro Biopharma
Series EJul 2018$85M
$110M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Principia Biopharma
Series BAug 2015$15M
Series BApr 2014$50M
Series AOct 2012$13M
$78M
Co-investors: Peter Thompson (OrbiMed), Simeon J. George (SR One), Nassim Usman (Ribozyme Pharmaceuticals)
Advanced Cell Diagnostics
Series CJun 2015$22M
Series BNov 2012$12M
$34M
Dimension Therapeutics
Series BApr 2015$65M
$65M
Co-investors: Ben Auspitz (Forge Life Science Partners)
Versartis
Series EFeb 2014$55M
Series DOct 2013$20M
Series CJul 2013$12M
Series CJan 2013$25M
Series BFeb 2011$21M
$130M
Co-investors: Shahzad Malik (Advent Life Sciences)
Principal Boston Consulting Group (BCG)Present
Board of Directors Advanced Cell Diagnostics, Inc.Present
Board of Directors Advanced Cell Diagnostics (ACD)Present
Board of Directors Aravive, Inc.Present
Board of Directors Principia BiopharmaPresent
Board of Directors Dimension TherapeuticsPresent
Board of Directors HotmailPresent
Partner New Leaf Venture PartnersPresent
Partner Samsara BioCapitalPresent
Partner HotmailPresent
Harvard University AB Biochemical Sciences
University of California, Berkeley PhD Molecular and Cellular Biology